Publications by authors named "H Wozniak"
Background: Critical illness is associated with an altered gut microbiota, yet its association with poor outcomes remains unclear. This study evaluates the early gut microbiota diversity changes in intensive care unit patients and its association with mortality. Additionally, it explores fecal pH as a potential biomarker for these changes.
View Article and Find Full Text PDFObjectives: Intubation is a common procedure in acute hypoxemic respiratory failure (AHRF), with minimal evidence to guide decision-making. We conducted a survey of when to intubate patients with AHRF to measure the influence of clinical variables on intubation decision-making and quantify variability.
Design: Factorial vignette-based survey asking "Would you recommend intubation?" Respondents selected an ordinal recommendation from a 5-point scale ranging from "Definite no" to "Definite yes" for up to ten randomly allocated vignettes.
Article Synopsis
- Many liver transplantation programs no longer require a set period of abstinence for candidates, but effective monitoring for ongoing alcohol use is necessary.
- Urinary ethyl glucuronide (EtG) testing is highlighted as an objective measure to detect alcohol consumption in patients with alcohol-associated liver disease (ALD) during the pretransplant phase.
- In a study of 497 ALD patients, only 8% tested positive for EtG, with severe alcohol use disorder, lower daily consumption, and prolonged substance use being significant factors linked to positive results; psychiatric issues were not strongly related.
Background: The decision to forgo life-sustaining treatment in intensive care units (ICUs) is influenced by ethical, cultural, and medical factors. This study focuses on a population of patients with hospital-acquired bloodstream infections (HABSI) to investigate the association between patient, pathogen, center and country-level factors and these decisions.
Methods: We analyzed data from the EUROBACT-2 study (June 2019-January 2021) from 265 centers worldwide, focusing on non-COVID-19 patients who died in the hospital or within 28 days after HABSI.